2[1]SACCO Rl,Roberts JK,Jacobs BS. Homocystein as a risk factor for ischemic stroke:an epidemiological story in evolution. Neuroepidemiology,1998,17:167-173.
3[2]Bostom AG,Rosenberg IH,Silbershatz H,et al. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons:the Framingham Study.Ann Intern Med.1999,131(5):352-355.
4[4]Tsai JC,Perrella MA,Yoshizumi M,et al. Promotion of vascular smooth muscle cell growth by homocysteine:a link to atherosclerosis. Proc Natl Acad Sci,1994,91:6369-6373.
5[5]Ling Q,Hajjar KA. Inhibition of endothelial cell thromboresistance by homocysteine. J Nutr,2000,130:373-376.
6[6]Harpel PC,Zhang X,Borth W.Homocysteine and hemostasis:pathogenic mechanisms predisposing to thrombosis. J Nutr,1996,126:1285-1289.
7[7]Midorikawa S,Sanada H,Hashimoto S. et al. Enhancement by homocysteine of plasminogen activator inhibitor-l gene expression and secretion from vascular endothelial and smooth muscle cells. Biochem-biophys-Res-commun,2000,272(1):182-185.
8[8]Khajuria A,Houston DS. Induction of monocyte tissue factor expression by homocysteine:a possible mechanism for thrombosis. Blood,2000,96(3):966-972.
9[9]Dardik R,Varon D,Tamarin I,et al. Homocysteine and oxidized low density lipoprotein enhances platelet adhesion to endothelial cells under flow conditions:distinct mechanisms of thrombogenic modulation. Thromb Haemost,2000,83:338-344.
10[10]Malinow MR,Kang SS,Taylor IM,et al. Prevalence of hyperhomocysteinemia in patients with peripheral arterial occlusive disease[J]. Circulation,1989,79(6):1180-1188.
4Boysen MJ,Goor ML,Koudstaal PJ. Plasma homocysteine is a risk factor for recurrent vascular events in young patients with an ischemic stroke or TIA[J].Neurology,2005,(03):332-337.
5Boysen G,Brander T,Christensen H. Homocysteine and risk of recurrent stroke[J].Stroke,2003,(05):1258-1261.
